Join the IDNLearn.com community and get your questions answered by knowledgeable individuals. Our Q&A platform offers reliable and thorough answers to ensure you have the information you need to succeed in any situation.
An introduction of recombinant DNA technology to pharmaceutical industry did NOT allow for: a. Improved drug safety b. High level of drug modification/alteration c. Mass-production of the biopharmaceuticals d. Higher average prices of the major biopharmaceuticals e. All of the above were the consequences of the switch to recombinant DNA technology in pharmaceutical industry
Sagot :
We value your presence here. Keep sharing knowledge and helping others find the answers they need. This community is the perfect place to learn together. IDNLearn.com provides the best answers to your questions. Thank you for visiting, and come back soon for more helpful information.
